Key Management Changes

Appointment:

  • Dr. Ashish Kumar Pandey has been appointed as Assistant Vice President - Operations (Cluster Head - Unit 2 & 3)
  • Designated as Senior Management Personnel of the Company
  • Effective date: November 2, 2026
  • Term of appointment: Not specified as applicable

Declassification:

  • Mr. Anurag Shukla, General Manager - Operations (Head Unit 2) ceases to be designated as Senior Management Personnel
  • Mr. Uday Desai, General Manager - Operations (Head Unit 3) ceases to be designated as Senior Management Personnel
  • Effective date: November 2, 2026, at close of business hours
  • Reason: Change in internal reporting structure - both managers will now report to Dr. Ashish Kumar Pandey instead of directly to any Executive Director

Continuity of Employment

Both Mr. Anurag Shukla and Mr. Uday Desai continue their employment with the Company without cessation of service. They will remain as Head of Unit 2 and Head of Unit 3 respectively under the new reporting structure.

Executive Profile

Dr. Ashish Kumar Pandey holds:

  • Doctorate in Operations and Management (Hons.)
  • M.Sc. in Chemistry from Madurai Kamaraj University
  • Over 30 years of experience in agrochemical, specialty chemicals, and pharmaceutical intermediates industries

Expertise includes:

  • Production and process management
  • Operations and management
  • Safety, Health, Quality, process safety, Environment (QHSE)
  • Plant commissioning
  • Greenfield and brownfield project management
  • Process debottlenecking, yield and quality improvement
  • Effluent treatment and technology transfer
  • Team and people management, innovation management, administration, and statutory liaison

Previous associations:

  • Benzochem Industries Private Limited
  • Dr. Acharya Laboratories Private Limited
  • Songwon Speciality Chemicals India Private Limited
  • Other companies in senior management roles

Governance Details

  • Dr. Ashish Kumar Pandey is not related to any Director or KMP of the Company
  • Changes approved by the Nomination and Remuneration Committee
  • Filed under SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026

Financial Impact

No financial impact quantified in the disclosure. The changes represent organizational restructuring without mentioned financial implications.